BRIEF published on 12/06/2024 at 07:05, 1 year 3 months ago Innate Pharma : Investissement de 7,9 millions de dollars pour IPH6501 Investissement Essai Clinique Innate Pharma Lymphome Folliculaire IPH6501
BRIEF published on 12/06/2024 at 07:05, 1 year 3 months ago Innate Pharma: Investment of 7.9 million dollars for IPH6501 Investment Clinical Trial Innate Pharma IPH6501 Follicular Lymphoma
PRESS RELEASE published on 12/06/2024 at 07:00, 1 year 3 months ago Informations privilégiées / Autres communiqués Innate Pharma et l'Institut d'Innovation pour le Lymphome Folliculaire (IFLI) signent un accord d'investissement jusqu'à 7,9 millions de dollars pour le développement d'IPH6501 dans le lymphome folliculaire Investissement Innate Pharma Lymphome Folliculaire IPH6501 IFLI
BRIEF published on 11/20/2024 at 07:05, 1 year 4 months ago Innate Pharma dévoile son calendrier financier pour 2025 Résultats Annuels Innate Pharma Calendrier Financier 2025 Assemblées Et Publications Cotisation Euronext Et Nasdaq
BRIEF published on 11/20/2024 at 07:05, 1 year 4 months ago Innate Pharma unveils its financial calendar for 2025 Annual Results Innate Pharma Financial Calendar 2025 Assemblies And Publications Euronext And Nasdaq Contribution
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 4 months ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2025 incluant les dates de publication des résultats et de l'assemblée générale, visant à informer les investisseurs et actionnaires Immunothérapie Événements Financiers Innate Pharma Biotechnologies Calendrier Financier 2025
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 4 months ago Inside Information / Other news releases Innate Pharma releases its 2025 financial calendar including key publication dates for financial statements and shareholder meetings Financial Statements Investors Financial Calendar 2025 Innate Pharma
BRIEF published on 11/08/2024 at 07:05, 1 year 4 months ago Innate Pharma présente ses innovations en oncologie au SITC 2024 Immunothérapie Innate Pharma NK Cell Engager SITC 2024 Conjugué Anticorps-médicament
BRIEF published on 11/08/2024 at 07:05, 1 year 4 months ago Innate Pharma presents its innovations in oncology at SITC 2024 Immunotherapy Innate Pharma SITC 2024 NK Cell Engage Antibody-drug Conjugate
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 4 months ago Informations privilégiées / Autres communiqués Annonce de Innate Pharma sur les présentations de données de son portefeuille innovant en oncologie sélectionnées pour le congrès annuel du SITC 2024 Immunothérapie Oncologie ADC Innate Pharma SITC 2024
Published on 03/27/2026 at 09:30, 1 hour 10 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 08:05, 2 hours 35 minutes ago Battery X Metals Announces Corporate Awareness Engagements
Published on 03/26/2026 at 23:00, 11 hours 40 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 12 hours 35 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 12 hours 40 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/27/2026 at 10:23, 17 minutes ago Original-Research: HORNBACH Holding AG & Co. KGaA (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 03/27/2026 at 10:00, 40 minutes ago AlphaPet Ventures welcomes Cpro Food, one of the leading super-premium brands for dog and cat food in Belgium
Published on 03/27/2026 at 09:45, 55 minutes ago DESTINUS Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026
Published on 03/27/2026 at 09:39, 1 hour ago Grünenthal achieves outstanding financial results in 2025, powered by strategic growth, integration and diversification
Published on 03/27/2026 at 09:37, 1 hour 3 minutes ago MEDICLIN lays a solid foundation for further growth with its 2025 financial results
Published on 03/27/2026 at 07:00, 3 hours 40 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 16 hours 23 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 16 hours 23 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 16 hours 40 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
